Release Date: 11/02/22 08:46 Summary: Minimum Holding Buyback Price Sensitive: No Download Document 499.09KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%